Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)
Clinical trial NCT01757197 · TERMINATED
Trial details
- NCT number
- NCT01757197
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-07
- Primary completion
- 2014-06-17
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.